Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver - PubMed (original) (raw)
Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver
E P Sandgren et al. Mol Cell Biol. 1993 Jan.
Abstract
To characterize the effect(s) of transforming growth factor alpha (TGF alpha) during multistage carcinogenesis, we examined tumor development in pancreas and liver of transgenic mice that coexpressed TGF alpha with either viral (simian virus 40 T antigens [TAg]) or cellular (c-myc) oncogenes. In pancreas, TGF alpha itself was not oncogenic, but it nevertheless dramatically accelerated growth of tumors induced by either oncogene alone, thereby reducing the host life span up to 60%. Coexpression of TGF alpha and TAg produced an early synergistic growth response in the entire pancreas together with the more rapid appearance of preneoplastic foci. Coexpression of TGF alpha and c-myc also accelerated tumor growth in situ and produced transplantable acinar cell carcinomas whose rate of growth was TGF alpha dependent. In liver, expression of TGF alpha alone increased the incidence of hepatic cancer in aged mice. However, coexpression of TGF alpha with c-myc or TAg markedly reduced tumor latency and accelerated tumor growth. Significantly, expression of the TGF alpha and myc transgenes in hepatic tumors was induced up to 20-fold relative to expression in surrounding nonneoplastic liver, suggesting that high-level overexpression of these proteins acts as a major stimulus for tumor development. Finally, in both pancreas and liver, combined expression of TGF alpha and c-myc produced tumors with a more malignant (less differentiated) appearance than did expression of c-myc alone, consistent with an influence of TGF alpha upon the morphological character of c-myc-induced tumor progression. These findings demonstrate the importance of TGF alpha expression during multistage carcinogenesis in vivo and point to a major role for this growth factor as a potent stimulator of tumor growth.
Similar articles
- Interaction of c-myc with transforming growth factor alpha and hepatocyte growth factor in hepatocarcinogenesis.
Thorgeirsson SS, Santoni-Rugiu E. Thorgeirsson SS, et al. Mutat Res. 1997 May 12;376(1-2):221-34. doi: 10.1016/s0027-5107(97)00047-x. Mutat Res. 1997. PMID: 9202759 - Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC. Sandgren EP, et al. Cancer Res. 1995 Sep 1;55(17):3915-27. Cancer Res. 1995. PMID: 7641211 - Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM, Thorgeirsson SS. Santoni-Rugiu E, et al. Am J Pathol. 1996 Aug;149(2):407-28. Am J Pathol. 1996. PMID: 8701981 Free PMC article. - Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer.
Calvisi DF, Thorgeirsson SS. Calvisi DF, et al. Toxicol Pathol. 2005;33(1):181-4. doi: 10.1080/01926230590522095. Toxicol Pathol. 2005. PMID: 15805070 Review. - TGF beta regulation of cell proliferation.
Moses HL, Arteaga CL, Alexandrow MG, Dagnino L, Kawabata M, Pierce DF Jr, Serra R. Moses HL, et al. Princess Takamatsu Symp. 1994;24:250-63. Princess Takamatsu Symp. 1994. PMID: 8983080 Review.
Cited by
- Old plasma dilution reduces human biological age: a clinical study.
Kim D, Kiprov DD, Luellen C, Lieb M, Liu C, Watanabe E, Mei X, Cassaleto K, Kramer J, Conboy MJ, Conboy IM. Kim D, et al. Geroscience. 2022 Dec;44(6):2701-2720. doi: 10.1007/s11357-022-00645-w. Epub 2022 Aug 24. Geroscience. 2022. PMID: 35999337 Free PMC article. - Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
Khan MA, Azim S, Zubair H, Bhardwaj A, Patel GK, Khushman M, Singh S, Singh AP. Khan MA, et al. Int J Mol Sci. 2017 Apr 6;18(4):779. doi: 10.3390/ijms18040779. Int J Mol Sci. 2017. PMID: 28383487 Free PMC article. Review. - Oncogenic KRAS and the EGFR loop in pancreatic carcinogenesis-A connection to licensing nodes.
Schneeweis C, Wirth M, Saur D, Reichert M, Schneider G. Schneeweis C, et al. Small GTPases. 2018 Nov 2;9(6):457-464. doi: 10.1080/21541248.2016.1262935. Epub 2017 Jan 20. Small GTPases. 2018. PMID: 27880072 Free PMC article. Review. - Kras(G12D) induces EGFR-MYC cross signaling in murine primary pancreatic ductal epithelial cells.
Diersch S, Wirth M, Schneeweis C, Jörs S, Geisler F, Siveke JT, Rad R, Schmid RM, Saur D, Rustgi AK, Reichert M, Schneider G. Diersch S, et al. Oncogene. 2016 Jul 21;35(29):3880-6. doi: 10.1038/onc.2015.437. Epub 2015 Nov 23. Oncogene. 2016. PMID: 26592448 Free PMC article. - Smad4 loss synergizes with TGFα overexpression in promoting pancreatic metaplasia, PanIN development, and fibrosis.
Garcia-Carracedo D, Yu CC, Akhavan N, Fine SA, Schönleben F, Maehara N, Karg DC, Xie C, Qiu W, Fine RL, Remotti HE, Su GH. Garcia-Carracedo D, et al. PLoS One. 2015 Mar 24;10(3):e0120851. doi: 10.1371/journal.pone.0120851. eCollection 2015. PLoS One. 2015. PMID: 25803032 Free PMC article.
References
- Anal Biochem. 1983 Jun;131(2):385-93 - PubMed
- Proc Natl Acad Sci U S A. 1985 Jul;82(13):4438-42 - PubMed
- Science. 1986 Jun 6;232(4755):1250-3 - PubMed
- Mol Cell Biol. 1986 Mar;6(3):870-7 - PubMed
- Proc Natl Acad Sci U S A. 1986 Nov;83(21):8167-71 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases